1
|
Sharps K, Foster J, Vieno M, Beck R, Hayes F. Ozone pollution contributes to the yield gap for beans in Uganda, East Africa, and is co-located with other agricultural stresses. Sci Rep 2024; 14:8026. [PMID: 38580752 PMCID: PMC10997645 DOI: 10.1038/s41598-024-58144-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Accepted: 03/26/2024] [Indexed: 04/07/2024] Open
Abstract
Air quality negatively impacts agriculture, reducing the yield of staple food crops. While measured data on African ground-level ozone levels are scarce, experimental studies demonstrate the damaging impact of ozone on crops. Common beans (Phaseolus vulgaris), an ozone-sensitive crop, are widely grown in Uganda. Using modelled ozone flux, agricultural surveys, and a flux-effect relationship, this study estimates yield and production losses due to ozone for Ugandan beans in 2015. Analysis at this scale allows the use of localised data, and results can be presented at a sub-regional level. Soil nutrient stress, drought, flood risk, temperature and deprivation were also mapped to investigate where stresses may coincide. Average bean yield losses due to ozone were 17% and 14% (first and second growing season respectively), equating to 184 thousand tonnes production loss. However, for some sub-regions, losses were up to 27.5% and other crop stresses also coincided in these areas. This methodology could be applied widely, allowing estimates of ozone impact for countries lacking air quality and/or experimental data. As crop productivity is below its potential in many areas of the world, changing agricultural practices to mitigate against losses due to ozone could help to reduce the crop yield gap.
Collapse
Affiliation(s)
- K Sharps
- UK Centre for Ecology & Hydrology, Environment Centre Wales, Deiniol Road, Bangor, Gwynedd, LL57 2UW, UK.
| | - J Foster
- UK Centre for Ecology & Hydrology, Environment Centre Wales, Deiniol Road, Bangor, Gwynedd, LL57 2UW, UK
| | - M Vieno
- UK Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian, EH26 0QB, UK
| | - R Beck
- UK Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian, EH26 0QB, UK
| | - F Hayes
- UK Centre for Ecology & Hydrology, Environment Centre Wales, Deiniol Road, Bangor, Gwynedd, LL57 2UW, UK
| |
Collapse
|
2
|
Wilson D, Ng V, Foster J, Tay L. Character Traits Predict Health and Well-Being beyond Personality. J Pers Assess 2024; 106:116-126. [PMID: 37036124 DOI: 10.1080/00223891.2023.2197064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2022] [Accepted: 03/19/2023] [Indexed: 04/11/2023]
Abstract
We examined the incremental validity of character in predicting health outcomes and well-being beyond personality traits and investigated the extent to which health-related behaviors mediate the relationship between character and well-being. Findings indicate that several character cores (e.g., transcendence, fortitude) predict well-being, health behaviors, and health outcomes beyond different measures of personality traits, indicating that character is discriminable from personality as indicated by incremental prediction. In particular, fortitude, temperance, transcendence, and sincerity appear to be key players. Implications for character research are discussed.
Collapse
Affiliation(s)
| | - Vincent Ng
- Department of Psychology, University of Houston, Houston
| | - Jeff Foster
- Department of Psychology, Missouri State University, Springfield
| | - Louis Tay
- Department of Psychological Sciences, Purdue University, West Lafayette
| |
Collapse
|
3
|
Chen A, Sharon E, Van Tine B, Moore N, Foster J, Glod J, Hu J, Rosenberger C, O'Sullivan Coyne G, Doroshow J. 49MO Atezolizumab and bevacizumab in patients treated with prior atezolizumab in alveolar soft tissue sarcoma (ASPS). ESMO Open 2023. [DOI: 10.1016/j.esmoop.2023.101086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
|
4
|
Hackett G, Kirby M, Rees RW, Jones TH, Muneer A, Livingston M, Ossei-Gerning N, David J, Foster J, Kalra PA, Ramachandran S. The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice. World J Mens Health 2023:41.e33. [PMID: 36876744 DOI: 10.5534/wjmh.221027] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2022] [Revised: 11/07/2022] [Accepted: 11/23/2022] [Indexed: 03/02/2023] Open
Abstract
Testosterone deficiency (TD) is an increasingly common problem with significant health implications, but its diagnosis and management can be challenging. A multi-disciplinary panel from BSSM reviewed the available literature on TD and provide evidence-based statements for clinical practice. Evidence was derived from Medline, EMBASE and Cochrane searches on hypogonadism, testosterone therapy (T Therapy) and cardiovascular safety from May 2017 to September 2022. This revealed 1,714 articles, including 52 clinical trials and 32 placebo-controlled randomised controlled trials. A total of twenty-five statements are provided, relating to five key areas: screening, diagnosis, initiating T Therapy, benefits and risks of T Therapy, and follow-up. Seven statements are supported by level 1 evidence, eight by level 2, five by level 3, and five by level 4. Recent studies have demonstrated that low levels of testosterone in men are associated with increased risk of incident type 2 diabetes mellitus, worse outcomes in chronic kidney disease and COVID 19 infection with increased all-cause mortality, along with significant quality of life implications. These guidelines should help practitioners to effectively diagnose and manage primary and age-related TD.
Collapse
Affiliation(s)
- Geoffrey Hackett
- Department of Urology, Spire Hospital, Little Aston, Birmingham, UK.,Department of Urology, Aston University, Birmingham, UK.
| | - Michael Kirby
- Trends in Urology and Men's Health, Letchworth, UK.,Faculty of Health & Human Sciences, University of Hertfordshire & The Prostate Centre, London, UK
| | - Rowland W Rees
- Department of Urology, University Hospital Southampton and UCLH, London, UK
| | - T Hugh Jones
- Department of Endocrinology, Barnsley Hospital, Barnsley, UK.,Department of Biochemistry, Royal Hallamshire Hospital, University of Sheffield Medical School, Sheffield, UK
| | - Asif Muneer
- Division of Surgery and Interventional Science, NIHR Biomedical Research Centre UCLH, London, UK
| | - Mark Livingston
- Department of Biochemistry, Black Country Pathology Services, Walsall Manor Hospital, Walsall, UK
| | - Nick Ossei-Gerning
- Cardiff and Vale NHS Trust, Cardiff, UK.,University of South Wales TDS, Bridgend, UK.,Department of Cardiology, University of Cape Coast, Cape Coast, Ghana
| | | | | | - Philip A Kalra
- Department of Nephrology, NCA, Salford Royal Hospital, Salford, UK
| | - Sudarshan Ramachandran
- Department of Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust, Sutton Coldfield, West Midlands, UK
| |
Collapse
|
5
|
Mistry PK, Kishnani P, Wanner C, Dong D, Bender J, Batista JL, Foster J. Rare lysosomal disease registries: lessons learned over three decades of real-world evidence. Orphanet J Rare Dis 2022; 17:362. [PMID: 36244992 PMCID: PMC9573793 DOI: 10.1186/s13023-022-02517-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Accepted: 09/04/2022] [Indexed: 12/24/2022] Open
Abstract
Lysosomal storage disorders (LSD) are rare diseases, caused by inherited deficiencies of lysosomal enzymes/transporters, that affect 1 in 7000 to 1 in 8000 newborns. Individuals with LSDs face long diagnostic journeys during which debilitating and life-threatening events can occur. Clinical trials and classical descriptions of LSDs typically focus on common manifestations, which are not representative of the vast phenotypic heterogeneity encountered in real-world experience. Additionally, recognizing that there was a limited understanding of the natural history, disease progression, and real-world clinical outcomes of rare LSDs, a collaborative partnership was pioneered 30 years ago to address these gaps. The Rare Disease Registries (RDR) (for Gaucher, Fabry, Mucopolysaccharidosis type I, and Pompe), represent the largest observational database for these LSDs. Over the past thirty years, data from the RDRs have helped to inform scientific understanding and the development of comprehensive monitoring and treatment guidelines by creating a framework for data collection and establishing a standard of care, with an overarching goal to improve the quality of life of affected patients. Here, we highlight the history, process, and impact of the RDRs, and discuss the lessons learned and future directions.
Collapse
Affiliation(s)
- P K Mistry
- Department of Medicine, Yale Liver Center, Yale University School of Medicine, 333 Cedar Street, PO Box 208019, New Haven, CT, 06520, USA.
| | - P Kishnani
- Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, USA
| | - C Wanner
- University Hospital of Würzburg, Würzburg, Germany
| | - D Dong
- Global Operations and Advocacy Lead, Rare Disease Registries, Sanofi, Cambridge, MA, USA
| | - J Bender
- Head of Global Rare Disease Registries, Sanofi, Cambridge, MA, USA
| | - J L Batista
- Epidemiology/Biostatistics, Sanofi, Cambridge, MA, USA
| | - J Foster
- Data Management, Sanofi, Cambridge, MA, USA
| |
Collapse
|
6
|
Jackson L, Mcneeley E, Techarukpong NC, Mugeta F, Aaron K, Mudano A, Merchant J, Warren K, Foster J, Saag K, Danila M. POS1147 CHALLENGES IN CONDUCTING PRAGMATIC CARE STRATEGY STUDIES IN OSTEOPOROSIS: PATIENT PERCEPTIONS. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.2473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundLarge pragmatic osteoporosis studies to improve outcomes are needed. Direct-to-patient studies have highest generalizability but achieving sufficient sample size is difficult; recruitment challenges represent an important consideration given limited participant eligibility and interest. The Fracture Liaison Service (FLS), a team approach to post-fracture care, is a secondary fracture prevention method that has significantly improved outcomes internationally.ObjectivesOur goal was to evaluate the interest, barriers, and lessons learned in recruiting participants for a future trial assessing remote FLS approaches for post-fracture care.MethodsWe used ICD10 fracture codes to identify patients > 50 years of age with a documented hip/pelvis, spine, humerus, or wrist fracture in the previous 1 year. We excluded patients with i) prescriptions for osteoporosis medications (e.g., bisphosphonates, parathyroid hormone analogs, denosumab, romosozumab, raloxifene) in the prior 1 year; ii) an ICD10 code for end-stage renal disease, non-osteoporotic metabolic bone disease, malignant neoplasm, or motor vehicle accident. In December 2021, research assistants reviewed electronic health records (EHR) of potentially eligible patients for evidence of additional serious illness limiting life expectancy to < 1 year or non-ambulatory status prior to fracture. Research assistants called preliminary eligible patients that met inclusion and exclusion criteria and asked them to complete a survey by phone. Interest in a FLS future clinical trial was evaluated using a Likert scale (1=“Definitely would not volunteer”, to 5=“Definitely would volunteer”). We used descriptive statistics to analyze baseline demographic, clinical characteristics, and interest. This pilot was approved by the UAB Institutional Review Board (IRB-300008310-005).ResultsWe identified 1,577 patients > 50 years of age with a fracture. After applying exclusion criteria, we identified 869 preliminary eligible patients. Over 3 weeks, we screened the medical records of a random sample of half of the preliminary eligible patient cohort (n=414), of whom we contacted 271 patients determined potentially eligible, and successfully reached 141 (52% of those contacted) by phone. A total of 108 (77% of those reached) persons, mean (SD) age 69.5 (11.5) years, 40% men, 21% Black or non-white Hispanics completed the survey. Among those contacted, 68 (63%, interest rate) said they would be very or highly interested in participating in a future clinical trial evaluating FLS approaches. Among the 40 (37%) people who said they were not sure, unlikely or very unlikely to volunteer the most common reasons cited were “I don’t want to participate in a study” (33%); “I don’t feel well enough to participate” (10%); “I don’t understand what the study is for” (3%). From this pilot, we calculated a refined eligibility/interest rate of 9.1% among those patients preliminarily identified as eligible using administrative data alone.ConclusionBased on our pilot, we estimate that approximately 9% of eligible patients with fractures will be interested in enrolling in a future comparative effectiveness study to prevent recurrent fragility fractures. We identified several potential modifiable barriers to clinical trial recruitment. Patient perceptions collected from this pilot will inform enrollment strategies, which can be incorporated early when planning direct-to-patient pragmatic osteoporosis studies to achieve recruitment goals.Disclosure of InterestsLesley Jackson: None declared, Ellen McNeeley: None declared, Norma C. Techarukpong: None declared, Faith Mugeta: None declared, Kiara Aaron: None declared, Amy Mudano: None declared, Jeanne Merchant: None declared, Kellie Warren: None declared, Jeff Foster: None declared, Kenneth Saag Grant/research support from: Amgen, Horizon, LG Chem, Radius, SOBI, Maria Danila Grant/research support from: Pfizer, Horizon
Collapse
|
7
|
Peterson C, Kim YC, Ensign LM, Jun AS, Foster J. Induction of the integrated stress response in the rat cornea. Exp Eye Res 2021; 210:108722. [PMID: 34370978 DOI: 10.1016/j.exer.2021.108722] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 07/13/2021] [Accepted: 08/05/2021] [Indexed: 11/19/2022]
Abstract
Keratoconus (KC), a progressive, degenerative corneal disease, represents the second leading indication for corneal transplantation globally. We have previously demonstrated that components of the Integrated Stress Response (ISR) are upregulated in human keratoconic donor tissue, and treatment of normal tissue with ISR agonists attenuates collagen production. With no consistently accepted animal models available for translational KC research, we sought to establish an in vivo model based on ISR activation to elucidate its role in the development of the KC phenotype. Four-week-old female SD rats were treated with topical SAL003 formulated as a nanosuspension or vehicle every 48 h for four doses. Animals were subject to monitoring for ocular inflammation and discomfort before being euthanized at 1, 14, or 28 days after treatment was withdrawn. Schirmer's tear test, intraocular pressure, and body weight measurements were obtained at baseline and prior to euthanasia. Globes were subject to routine histopathology, immunohistochemistry for ATF4, and qPCR for Col1a1 expression. ANOVAs and Student's t tests were used to assess statistical significance (α = 0.05). SAL003 treatment did not produce any adverse ocular or systemic phenotype but did result in decreased keratocyte density. Col1a1 transcripts were reduced, corresponding to nuclear ATF4 expression within the axial cornea. In vivo topical treatment with a gel-formulated ISR agonist recapitulates key features of the activated ISR including nuclear ATF4 expression and decreased extracellular matrix (ECM) production. Exogenous ISR agonists may present one approach to establishing a rodent model for keratoconus, a charge essential for future evaluations of pathogenesis and therapeutic interventions.
Collapse
Affiliation(s)
- C Peterson
- Department of Molecular & Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Y C Kim
- Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - L M Ensign
- Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - A S Jun
- Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - J Foster
- Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
| |
Collapse
|
8
|
Shadbolt T, Sainsbury AW, Foster J, Bernhard T. Risks from poorly planned conservation translocations. Vet Rec 2021; 188:269. [PMID: 33835551 DOI: 10.1002/vetr.373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- T Shadbolt
- Disease Risk Analysis and Health Surveillance, Institute of Zoology, Zoological Society of London, London, NW1 4RY
| | - A W Sainsbury
- Disease Risk Analysis and Health Surveillance, Institute of Zoology, Zoological Society of London, London, NW1 4RY
| | - J Foster
- Amphibian and Reptile Conservation, Witley Centre, Witley, Godalming, Surrey, GU8 5QA
| | - T Bernhard
- Natural England, Eastleigh House, Upper Market Street, Eastleigh, Hampshire, SO50 9YN
| |
Collapse
|
9
|
Khanna P, Khanna D, Cutter G, Foster J, Melnick J, Jaafar S, Biggers S, Rahman F, Kuo HC, Feese M, Saag K. POS0135 REDUCING IMMUNOGENICITY OF PEGLOTICASE (RECIPE) WITH CONCOMITANT USE OF MYCOPHENOLATE MOFETIL IN PATIENTS WITH REFRACTORY GOUT: A PHASE II RANDOMIZED CONTROLLED TRIAL. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3111] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Pegloticase is a recombinant, pegylated uricase, used for treatment of gout patients who fail oral urate lowering therapy (ULT). Its use has been limited due to immunogenicity leading to infusion reactions.1Objectives:We evaluated if co-administration of an immunomodulatory agent could prolong the efficacy of pegloticase.Methods:Participants were recruited in a Phase II, double-blind, placebo-controlled trial over 18 months and randomized in a 3:1 ratio by site. Inclusion criteria were: a) Age ≥ 18 years who met 2015 ACR/EULAR gout classification criteria and b) chronic refractory gout defined as symptoms inadequately controlled with ULT or contraindications. After a 2-week run-in of mycophenolate mofetil (MMF) 1000 mg twice daily or matching placebo (PBO), they received a combination of pegloticase 8 mg biweekly with MMF or PBO for 12 weeks. Subsequent to this MMF or PBO were discontinued but pegloticase was continued for another 12 weeks. The primary endpoint was proportion of patients who sustained a serum urate (SU) level of ≤ 6 mg/dl at 12 weeks. Secondary endpoints included 24-week durability of SU ≤ 6 mg/dl and rate of adverse events (AEs). Fisher’s exact test and Wilcoxon two-sample test were used for analyses along with Kaplan-Meier estimates and log-rank tests to compare survival curves between groups. Hypothesis tests were two-tailed and p-value (p) < 0.05 indicated statistical significance.Results:Of 42 subjects screened, 35 were randomized, and 32 who received at least one dose of pegloticase were included in modified intention to treat analyses. Subjects were predominantly men (88%), mean age of 55.2 years (SD=9.7). Mean duration of gout was 13.4 years (SD=9.0), mean baseline sUA was 9.2 mg/dL (SD=1.6). Tophi were present in 88% and majority were on optimized ULT - 59% on allopurinol and 16% on febuxostat, with 63% reporting > 1 flare in the past year. At baseline both arms (MMF vs. PBO) had similar comorbidities – (82% vs 70%), diabetes mellitus/metabolic syndrome (14% vs 20%), coronary artery disease/peripheral vascular disease (41% vs.70%), BMI>30 (86% vs. 90%) and renal insufficiency (defined as eGFR < 90 mL/min; 73% vs. 70%). At 12 weeks, 19 of 22 (86%) in the MMF arm achieved SU ≤ 6 mg/dl compared to 4 of 10 (40%) in PBO arm (p-value = 0.01). At 24 weeks, the SU was ≤ 6 mg/dl in 68% of MMF arm vs. 30% in PBO (p-value = 0.06), and rates of AEs per month were similar between groups with the PBO arm having more infusion reactions (30% vs. 0%). The MMF arm had higher AEs compared to placebo: musculoskeletal (41% vs. 10%), gastrointestinal (18% vs. 10%), and infections (9% vs. 0%). Figure 1 shows that the percentage of subjects maintaining a sUA < 6 mg/dL at 12 weeks was significantly higher (p=0.02) in the MMF arm, and a significant difference (p=0.03) at 24 weeks indicates sustained benefit from MMF.Conclusion:To our knowledge this is the first randomized-controlled proof of concept trial to demonstrate the ability of an immunomodulatory agent in prolonging the efficacy of pegloticase. Short-term concomitant use of MMF therapy with pegloticase was well tolerated and showed a clinically meaningful improvement in the targeted SU ≤6 mg/dL at 12 and 24 weeks. This study suggests an innovative approach to utilize pegloticase therapy in patients with chronic gout.References:[1]Sundy et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011;306(7):711-20.Figure 1.Proportion of subjects maintaining serum urate (SU) ≤ 6 mg/dL over 24 week study period in mycophenolate mofetil + pegloticase vs. placebo + pegloticaseDisclosure of Interests:Puja Khanna Consultant of: Horizon Pharmaceuticals, Swedish Orphan Biovitrum A, Grant/research support from: Selecta, 2)DYVE, Dinesh Khanna Consultant of: Horizon Pharmaceuticals, Gary Cutter: None declared, Jeff Foster: None declared, Josh Melnick: None declared, Sara Jaafar: None declared, Stephanie Biggers: None declared, Fazlur Rahman: None declared, Hui-Chen Kuo: None declared, Michelle Feese: None declared, Kenneth Saag Consultant of: AbbVie, Inc., Bayer, Daiichi Sankyo Company LTD, Gilead Services, Inc., Horizon Pharma plc, Mallinkrodt, Radius Health, Inc., Roche/Genentech, Shanton Pharma Co., LTD, Teijin, Dyve Bioscience, LG Chem, Regeneron Pharmaceuticals., Swedish Orphan Biovitrum AB, Takeda Pharmaceuticals America, Inc.,
Collapse
|
10
|
Khanna PP, Khanna D, Cutter G, Foster J, Melnick J, Jaafar S, Biggers S, Rahman AKMF, Kuo HC, Feese M, Kivitz A, King C, Shergy W, Kent J, Peloso PM, Danila MI, Saag KG. Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 2021; 73:1523-1532. [PMID: 33750034 DOI: 10.1002/art.41731] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 02/18/2021] [Accepted: 03/09/2021] [Indexed: 12/19/2022]
Abstract
OBJECTIVE Pegloticase is used for the treatment of severe gout, but its use is limited by immunogenicity. This study was undertaken to evaluate whether mycophenolate mofetil (MMF) prolongs the efficacy of pegloticase. METHODS Participants were randomized 3:1 to receive 1,000 mg MMF twice daily or placebo for 14 weeks, starting 2 weeks before receiving pegloticase and continuing while receiving intravenous pegloticase 8 mg biweekly for 12 weeks. Participants then received pegloticase alone from week 12 to week 24. The primary end points were the proportion of patients who sustained a serum urate level of ≤6 mg/dl at 12 weeks and the rate of adverse events (AEs). Secondary end points included 24-week durability of serum urate level ≤6 mg/dl. Fisher's exact test and Wilcoxon's 2-sample test were used for analyses, along with Kaplan-Meier estimates and log rank tests. RESULTS A total of 32 participants received ≥1 dose of pegloticase. Participants were predominantly men (88%), with a mean age of 55.2 years, mean gout duration of 13.4 years, and mean baseline serum urate level of 9.2 mg/dl. At 12 weeks, a serum urate level of ≤6 mg/dl was achieved in 19 (86%) of 22 participants in the MMF arm compared to 4 (40%) of 10 in the placebo arm (P = 0.01). At week 24, the serum urate level was ≤6 mg/dl in 68% of MMF-treated patients versus 30% of placebo-treated patients (P = 0.06), and rates of AEs were similar between groups, with more infusion reactions occurring in the placebo arm (30% versus 0%). CONCLUSION Our findings indicate that MMF therapy with pegloticase is well tolerated and shows a clinically meaningful improvement in targeted serum urate level of ≤6 mg/dl at 12 and 24 weeks. This study suggests an innovative approach to pegloticase therapy in gout.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Alan Kivitz
- Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA
| | | | | | - Jeff Kent
- Horizon Therapeutics, Lake Forest, Illinois, USA
| | | | | | | |
Collapse
|
11
|
MacNally S, Smith C, Spaulding J, Foster J, Oliver JB. Glancing-angle-deposited silica films for ultraviolet wave plates. Appl Opt 2020; 59:A155-A161. [PMID: 32225368 DOI: 10.1364/ao.59.00a155] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Accepted: 12/03/2019] [Indexed: 06/10/2023]
Abstract
Birefringent silica films are formed by glancing-angle deposition to fabricate quarter- and half-wave plates at a wavelength of 351 nm. A multilayer design is implemented to achieve low-loss transmittance with a high 351-nm laser-induced damage threshold.
Collapse
|
12
|
Parker S, Foster J, Whiddon C, Pacholke H. Optimizing Skin Dose for Post-Mastectomy Chestwall VMAT Radiation Therapy. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.874] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
White TG, Oliver MT, Mabey P, Kühn-Kauffeldt M, Bott AFA, Döhl LNK, Bell AR, Bingham R, Clarke R, Foster J, Giacinti G, Graham P, Heathcote R, Koenig M, Kuramitsu Y, Lamb DQ, Meinecke J, Michel T, Miniati F, Notley M, Reville B, Ryu D, Sarkar S, Sakawa Y, Selwood MP, Squire J, Scott RHH, Tzeferacos P, Woolsey N, Schekochihin AA, Gregori G. Supersonic plasma turbulence in the laboratory. Nat Commun 2019; 10:1758. [PMID: 30988285 PMCID: PMC6465398 DOI: 10.1038/s41467-019-09498-y] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Accepted: 03/08/2019] [Indexed: 11/13/2022] Open
Abstract
The properties of supersonic, compressible plasma turbulence determine the behavior of many terrestrial and astrophysical systems. In the interstellar medium and molecular clouds, compressible turbulence plays a vital role in star formation and the evolution of our galaxy. Observations of the density and velocity power spectra in the Orion B and Perseus molecular clouds show large deviations from those predicted for incompressible turbulence. Hydrodynamic simulations attribute this to the high Mach number in the interstellar medium (ISM), although the exact details of this dependence are not well understood. Here we investigate experimentally the statistical behavior of boundary-free supersonic turbulence created by the collision of two laser-driven high-velocity turbulent plasma jets. The Mach number dependence of the slopes of the density and velocity power spectra agree with astrophysical observations, and supports the notion that the turbulence transitions from being Kolmogorov-like at low Mach number to being more Burgers-like at higher Mach numbers.
Collapse
Affiliation(s)
- T G White
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK.
- Department of Physics, University of Nevada, Reno, NV, 89557, USA.
| | - M T Oliver
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
- Department of Physics, University of Nevada, Reno, NV, 89557, USA
| | - P Mabey
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
- LULI-CNRS, Ecole Polytechnique, CEA: Université Paris-Saclay; UPMC Univ Paris 06: Sorbonne Universitiés, F-91128, Palaiseau cedex, France
| | | | - A F A Bott
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - L N K Döhl
- York Plasma Institute, Department of Physics, University of York, Heslington, York, YO10 5DD, UK
| | - A R Bell
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - R Bingham
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
- Department of Physics, SUPA, University of Strathclyde, Glasgow, G4 0NG, UK
| | - R Clarke
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
| | - J Foster
- AWE, Aldermaston, Reading, West Berkshire, RG7 4PR, UK
| | - G Giacinti
- Max-Planck-Institut für Kernphysik, Postfach 103980, 69029, Heidelberg, Germany
| | - P Graham
- AWE, Aldermaston, Reading, West Berkshire, RG7 4PR, UK
| | - R Heathcote
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
| | - M Koenig
- LULI-CNRS, Ecole Polytechnique, CEA: Université Paris-Saclay; UPMC Univ Paris 06: Sorbonne Universitiés, F-91128, Palaiseau cedex, France
- Graduate School of Engineering, Osaka University, Suita, Osaka, 564-0871, Japan
| | - Y Kuramitsu
- Graduate School of Engineering, Osaka University, Suita, Osaka, 564-0871, Japan
| | - D Q Lamb
- Department of Astronomy and Astrophysics, University of Chicago, 5640S. Ellis Ave, Chicago, IL, 60637, USA
| | - J Meinecke
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - Th Michel
- LULI-CNRS, Ecole Polytechnique, CEA: Université Paris-Saclay; UPMC Univ Paris 06: Sorbonne Universitiés, F-91128, Palaiseau cedex, France
| | - F Miniati
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - M Notley
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
| | - B Reville
- School of Mathematics and Physics, Queens University Belfast, Belfast, BT7 1NN, UK
| | - D Ryu
- Department of Physics, School of Natural Sciences, UNIST, Ulsan, 44919, Korea
| | - S Sarkar
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - Y Sakawa
- Institute of Laser Engineering, Osaka, 565-0871, Japan
| | - M P Selwood
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
| | - J Squire
- Theoretical Astrophysics, 350-17, California Institute of Technology, Pasadena, CA, 91125, USA
- Physics Department, University of Otago, Dunedin, 9016, New Zealand
| | - R H H Scott
- Central Laser Facility, STFC Rutherford Appleton Laboratory, Harwell Oxford, Didcot, OX11 0QX, UK
| | - P Tzeferacos
- Department of Astronomy and Astrophysics, University of Chicago, 5640S. Ellis Ave, Chicago, IL, 60637, USA
| | - N Woolsey
- York Plasma Institute, Department of Physics, University of York, Heslington, York, YO10 5DD, UK
| | - A A Schekochihin
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - G Gregori
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK.
| |
Collapse
|
14
|
Duffton A, McCrea I, Allwood-Spiers S, Hay L, Devlin L, Sankaralingam M, Thomson M, McLoone P, McJury M, Foster J, Paterson C. OC-0415 MERINO study: Defining a standardised delineation method for repeated GTV assessment using DW MRI. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30835-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Paterson C, McCrea I, Hay L, Allwood-Speirs S, Devlin L, Sankaralingam M, McLoone P, Wilson C, Grose D, James A, Lamb C, Rizwanullah M, Schipani S, Nixon I, Thomson M, McJury M, Foster J, Duffton A. EP-1137 DW MRI as biomarker of response during RT for intermed/high risk SCC oropharynx: a feasibility study. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31557-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Norris A, Crossland W, Tedeschi L, Foster J, Muir J, Pinchak W. 419 Effect of Differing Rates of Quebracho (Schinopsis balansae) Extract provided in a Limit-Fed High Roughage Total Mixed Ration Upon Digestibility and Nitrogen Balance. J Anim Sci 2018. [DOI: 10.1093/jas/sky404.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Norris
- Texas A&M University, College Station,College Station, TX, United States
| | - W Crossland
- Texas Tech University,Lubbock, TX, United States
| | - L Tedeschi
- Department of Animal Science, Texas A&M University-College Station,College Station, TX, United States
| | - J Foster
- Texas A&M AgriLife Research,Beeville, College station, TX, United States
| | - J Muir
- Texas A&M AgriLife Research,Stephenville, TX, United States
| | - W Pinchak
- Texas A&M AgriLife Research,Beeville, College station, TX, United States
| |
Collapse
|
17
|
Bagley A, Grosshans D, Philip N, McAleer M, McGovern S, Foster J, Mahajan A, Paulino A. Efficacy of Proton Therapy on Locoregional Control in Neuroblastoma. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Rudran B, Reader C, Foster J, Hodivala-Dilke K, Sosabowski J, Marshall J. P1.03-19 Antibody Blockade of Integrin Alpha-V-Beta-6 (avb6) as a Novel Treatment for NSCLC. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
19
|
Affiliation(s)
- J Foster
- College of Medicine and Dentistry, James Cook University, Townsville, Torres and Cape Tuberculosis Control Unit, Thursday Island, Queensland Health
| | - E McBryde
- Torres and Cape Tuberculosis Control Unit, Thursday Island, Queensland Health, Infectious Disease and Epidemiology, Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia
| | - M Taune
- Daru General Hospital, Daru, Western Province, Papua New Guinea
| | - D Peniyamina
- Cairns and Hinterland Hospital and Health Service, Cairns, QLD, Australia ,
| |
Collapse
|
20
|
Sharma S, Elfenbein HA, Foster J, Bottom WP. Predicting Negotiation Performance from Personality Traits: A field Study across Multiple Occupations. Human Performance 2018. [DOI: 10.1080/08959285.2018.1481407] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Sudeep Sharma
- Department of Management, University of Illinois at Springfield, Springfield, Illinois, United States
| | - Hillary Anger Elfenbein
- Olin Business School, Washington University in St. Louis, St. Louis, Missouri, United States
| | - Jeff Foster
- Research and Development, Hogan Assessments, Tulsa, Oklahoma, United States
| | - William P. Bottom
- Olin Business School, Washington University in St. Louis, St. Louis, Missouri, United States
| |
Collapse
|
21
|
Tzeferacos P, Rigby A, Bott AFA, Bell AR, Bingham R, Casner A, Cattaneo F, Churazov EM, Emig J, Fiuza F, Forest CB, Foster J, Graziani C, Katz J, Koenig M, Li CK, Meinecke J, Petrasso R, Park HS, Remington BA, Ross JS, Ryu D, Ryutov D, White TG, Reville B, Miniati F, Schekochihin AA, Lamb DQ, Froula DH, Gregori G. Laboratory evidence of dynamo amplification of magnetic fields in a turbulent plasma. Nat Commun 2018; 9:591. [PMID: 29426891 PMCID: PMC5807305 DOI: 10.1038/s41467-018-02953-2] [Citation(s) in RCA: 83] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Accepted: 01/09/2018] [Indexed: 11/25/2022] Open
Abstract
Magnetic fields are ubiquitous in the Universe. The energy density of these fields is typically comparable to the energy density of the fluid motions of the plasma in which they are embedded, making magnetic fields essential players in the dynamics of the luminous matter. The standard theoretical model for the origin of these strong magnetic fields is through the amplification of tiny seed fields via turbulent dynamo to the level consistent with current observations. However, experimental demonstration of the turbulent dynamo mechanism has remained elusive, since it requires plasma conditions that are extremely hard to re-create in terrestrial laboratories. Here we demonstrate, using laser-produced colliding plasma flows, that turbulence is indeed capable of rapidly amplifying seed fields to near equipartition with the turbulent fluid motions. These results support the notion that turbulent dynamo is a viable mechanism responsible for the observed present-day magnetization.
Collapse
Affiliation(s)
- P Tzeferacos
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
- Department of Astronomy and Astrophysics, University of Chicago, 5640 S. Ellis Ave, Chicago, IL, 60637, USA
| | - A Rigby
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - A F A Bott
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - A R Bell
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - R Bingham
- Rutherford Appleton Laboratory, Chilton, Didcot, OX11 0QX, UK
- Department of Physics, University of Strathclyde, Glasgow, G4 0NG, UK
| | - A Casner
- CEA, DAM, DIF, 91297, Arpajon, France
| | - F Cattaneo
- Department of Astronomy and Astrophysics, University of Chicago, 5640 S. Ellis Ave, Chicago, IL, 60637, USA
| | - E M Churazov
- Max Planck Institute for Astrophysics, Karl-Schwarzschild-Strasse 1, 85741, Garching, Germany
- Space Research Institute (IKI), Profsouznaya 84/32, Moscow, 117997, Russia
| | - J Emig
- Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA
| | - F Fiuza
- SLAC National Accelerator Laboratory, 2575 Sand Hill Road, Menlo Park, CA, 94025, USA
| | - C B Forest
- Physics Department, University of Wisconsin-Madison, 1150 University Avenue, Madison, WI, 53706, USA
| | - J Foster
- AWE, Aldermaston, Reading, West Berkshire, RG7 4PR, UK
| | - C Graziani
- Department of Astronomy and Astrophysics, University of Chicago, 5640 S. Ellis Ave, Chicago, IL, 60637, USA
| | - J Katz
- Laboratory for Laser Energetics, University of Rochester, 250 E. River Rd, Rochester, NY, 14623, USA
| | - M Koenig
- Laboratoire pour l'Utilisation de Lasers Intenses, UMR7605, CNRS CEA, Université Paris VI Ecole Polytechnique, 91128, Palaiseau Cedex, France
| | - C-K Li
- Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
| | - J Meinecke
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - R Petrasso
- Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
| | - H-S Park
- Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA
| | - B A Remington
- Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA
| | - J S Ross
- Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA
| | - D Ryu
- Department of Physics, UNIST, Ulsan, 689-798, Korea
| | - D Ryutov
- Lawrence Livermore National Laboratory, Livermore, CA, 94550, USA
| | - T G White
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - B Reville
- School of Mathematics and Physics, Queens University Belfast, Belfast, BT7 1NN, UK
| | - F Miniati
- Department of Physics, ETH Zürich, Wolfgang-Pauli-Strasse 27, Zürich, CH-8093, Switzerland
| | - A A Schekochihin
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK
| | - D Q Lamb
- Department of Astronomy and Astrophysics, University of Chicago, 5640 S. Ellis Ave, Chicago, IL, 60637, USA
| | - D H Froula
- Laboratory for Laser Energetics, University of Rochester, 250 E. River Rd, Rochester, NY, 14623, USA
| | - G Gregori
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU, UK.
- Department of Astronomy and Astrophysics, University of Chicago, 5640 S. Ellis Ave, Chicago, IL, 60637, USA.
| |
Collapse
|
22
|
Simonet DV, Tett RP, Foster J, Angelback AI, Bartlett JM. Dark-Side Personality Trait Interactions: Amplifying Negative Predictions of Leadership Performance. Journal of Leadership & Organizational Studies 2017. [DOI: 10.1177/1548051817727703] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Drawing on trait interaction theory and personality disorder subtypes, we examined narcissism-by-trait interactions (e.g., narcissism × antisocial tendencies) for predicting leadership performance in four independent archival samples ( Ns = 285, 120, 106, 559). This study extends research on multiplicative effects of normative leader characteristics to consider how narcissism becomes particularly disruptive when combined with other extreme interpersonal tendencies. Moderated multiple regression results show interactions involving selected trait pairs varied across samples. Pooled analyses showed (a) differential generalizability across trait pairings and (b) that lower tiered managerial roles and weaker industrial contexts may release such effects. Inconsistencies suggest the need to consider sample-specific trait demands in future trait interaction research, normal, or maladaptive. All told, findings suggest that subclinical personality interactions might accelerate leader derailment, offer unique insights into leader competence, and extend trait interaction research to aberrant tendencies.
Collapse
|
23
|
Mountjoy M, Costa A, Budgett R, Dvorak J, Engebretsen L, Miller S, Moran J, Foster J, Carr J. Health promotion through sport: international sport federations’ priorities, actions and opportunities. Br J Sports Med 2017; 52:54-60. [DOI: 10.1136/bjsports-2017-097900] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2017] [Revised: 05/14/2017] [Accepted: 05/17/2017] [Indexed: 11/03/2022]
Abstract
ObjectiveTo identify areas of priority and activity for international sportsfederations (IFs) with respect to athlete health and safety, and global health. Results serve to direct the work of the Association of Summer Olympic IF Medical and Scientific Consultative Group, the International Olympic Committee and to influence IFs’ planning and priorities.MethodsThe 28 IFs participating in the Summer Olympic Games (2016) were asked to rank the relative importance of 11 health-related topics and to report their activities or research initiatives on 27 identified topics using an electronic survey. A comparison with a similar survey (2012) was made.ResultsThe response rate was 100%. In general, the ‘fight against doping’ had the highest priority followed by ‘image as a safe sport’. The topics with the lowest importance ratings were ‘increasing the number of elite athletes’, and ‘health of the general population’. Despite ranking ‘health of your athletes,’ as a top priority, IFs are not addressing all aspects of athlete health. In comparison with 2012, there was a significant decrease in priority for IFs is ‘health of the general population’.ConclusionDespite the widespread knowledge of the importance of the promotion of physical activity (sport) on global health, the decreasing priority and programming of the IFs on physical activity promotion is concerning. Although IFs have prioritised the protection of the health of elite athletes, there are gaps in programming demonstrating that IFs are missing important areas of athlete health. Improving recreational athlete health programming could also benefit population health as well as improve IF fan base and sport participation.
Collapse
|
24
|
Bunyan M, Crowley J, Smedley N, Mutti MF, Cashen A, Thompson T, Foster J. Feasibility of training nurses in motivational interviewing to improve patient experience in mental health inpatient rehabilitation: a pilot study. J Psychiatr Ment Health Nurs 2017; 24:221-231. [PMID: 28248447 DOI: 10.1111/jpm.12382] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/24/2017] [Indexed: 11/30/2022]
Abstract
UNLABELLED WHAT IS KNOWN ON THE SUBJECT?: Recently, concerns have been raised about how well United Kingdom National Health Service nurses care for their patients and their level of compassion. Motivational interviewing (MI) is an established approach to helping people make positive behaviour changes, through directive, person-centred counselling within a collaborative relationship between clinician and recipient. Based on evidence that MI may influence nursing practice positively, an investigation into the feasibility of training nurses on mental health inpatient rehabilitation wards ('rehabilitation') in MI to improve patient experience was reported. WHAT THIS PAPER ADDS TO EXISTING KNOWLEDGE?: This pilot study demonstrates that training rehabilitation nurses in MI is feasible and provides preliminary evidence suggesting that a larger study to examine efficacy is warranted, including a calculation of sample size required to draw robust statistical conclusions. Nurses evaluated the training as highly relevant to their work. Patients responded well to interviews and focus groups with support from experts-by-experience; they were generally fairly satisfied with the rehabilitation ward and slight improvements in their experience were found following MI training for nurses but not at 6-month follow-up. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: Rehabilitation nurses may face conflicting demands between ensuring patients with severe difficulties meet their basic needs and working with them to develop greater independence. Qualitative findings question whether nurse-patient interactions are fully valued as nursing interventions in inpatient rehabilitation. Learning MI might be a useful way of helping nurses think in detail about their interactions with patients and how to improve communications with their patients. The principles of MI should be incorporated into pre-registration training. ABSTRACT Introduction There is limited research addressing the experiences of patients in inpatient rehabilitation (rehabilitation), who often spend long periods in hospital, and the nursing approaches utilized. Aim Based on evidence that motivational interviewing (MI) may improve nursing practice, this was a pilot study evaluating the feasibility of training rehabilitation nurses in MI and measuring patient experience. Method Nurses underwent training and supervision focusing on MI spirit. Quantitative and qualitative measures were taken pretraining, 2 months post-training and 8 months post-training. Expert-by-experience research assistants facilitated patients' participation in the study. Results This study showed that training rehabilitation nurses in MI was feasible and relevant to their work. Patients participated in interviews and focus groups with support and potential improvements that require further empirical investigation in patient experience were found following the MI training. Discussion This pilot study establishes the feasibility of a larger study addressing efficacy. Tentative qualitative findings question whether interactions between nurses and patients are valued in rehabilitation and support MI as a promising skill set for rehabilitation nurses. Implications for practice Bringing MI into inpatient rehabilitation provoked reflection on nursing practice. Dilemmas for nurses about balancing safety with promoting autonomy and communicating constructively with patients emerged as important.
Collapse
Affiliation(s)
- M Bunyan
- Oxleas NHS Foundation Trust, Dartford, UK
| | - J Crowley
- Faculty of Education and Health, University of Greenwich, London, UK
| | - N Smedley
- Oxleas NHS Foundation Trust, Dartford, UK
| | - M-F Mutti
- Oxleas NHS Foundation Trust, Dartford, UK
| | - A Cashen
- Oxleas NHS Foundation Trust, Dartford, UK
| | - T Thompson
- Faculty of Education and Health, University of Greenwich, London, UK
| | - J Foster
- Faculty of Education and Health, University of Greenwich, London, UK
| |
Collapse
|
25
|
Rudran B, Desai A, Luzarraga M, Hodivala-Dilke K, Foster J, Sosabowski J, Marshall J. 6: Development of non-invasive imaging of integrin alpha-v-beta-6 (αvβ6)-positive lung cancers in advance of testing αvβ6-targeted therapies. Lung Cancer 2017. [DOI: 10.1016/s0169-5002(17)30056-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Stone TH, Foster J, Webster BD, Harrison J, Jawahar IM. Gender differences in supervisors’ multidimensional performance ratings: Large sample evidence. Human Performance 2016. [DOI: 10.1080/08959285.2016.1224884] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
27
|
Zadeh S, Foster J. From 'Virgin Births' to 'Octomom': Representations of Single Motherhood via Sperm Donation in the UK News. J Community Appl Soc Psychol 2016; 26:551-566. [PMID: 27867283 PMCID: PMC5111753 DOI: 10.1002/casp.2288] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2015] [Revised: 08/13/2016] [Accepted: 08/25/2016] [Indexed: 11/22/2022]
Abstract
The use of sperm donation by single women has provoked public, professional and political debate. Newspapers serve as a critical means of both broadcasting this debate and effecting a representation of this user group within the public sphere. This study uses the theory of social representations to examine how single motherhood by sperm donation has been represented in the UK news over time. The study sampled news coverage on this topic in eight British newspapers during three 4-year periods between the years 1988 and 2012. The dataset of news reports (n = 406) was analysed using a qualitative approach. Findings indicated that UK media reports of single women using donor sperm are underpinned by conventional categories of the 'personal', the 'traditional' and the 'natural' that when paired with their corollaries produce a representation of this user group as the social 'other'. The amount of coverage on this topic over time was found to vary according to the political orientation of different media sources. Using key concepts from social representations theory, this article discusses the relationship between themata and anchoring in the maintenance of representations of the social 'other' in mass mediated communication. Findings are explained in relation to theoretical conceptions of the mass media and its position within the public sphere. It is argued that the use of personal narratives in news reports of single mothers by sperm donation may have significant implications for public understandings of this social group. © 2016 The Authors. Journal of Community & Applied Social Psychology published by John Wiley & Sons Ltd.
Collapse
Affiliation(s)
- S. Zadeh
- Centre for Family ResearchUniversity of CambridgeCambridgeUK
| | - J. Foster
- Department of PsychologyUniversity of CambridgeCambridgeUK
| |
Collapse
|
28
|
|
29
|
Abstract
Prior work examining the role of cultural groupings (i.e., national membership) on personal values showed small to moderate amounts of variability attributable to culture, refuting the idea that culture determines values. We extend this research by examining the proportion of variance in values that could be explained by cultural membership. Because there is no definitive level of proportion of variance that would lead to a conclusion that values are culturally determined, personality, which is arguably not culturally determined, was used as a relative benchmark. Language groups were used as an alternate conception of cultural groupings. A large data set of 144,857 workers from across 31 major language groups revealed that language groups explained a significant and non-negligible amount of variance in personal value dimensions (7%-17%). Nevertheless, this was not significantly larger than any single personality dimension (3%-12%). In other words, our data failed to support the notion that personal values are strongly determined by cultural groupings compared with personality.
Collapse
Affiliation(s)
- Vincent Ng
- Purdue University, West Lafayette, IN, USA
| | | | - Louis Tay
- Purdue University, West Lafayette, IN, USA
| | | |
Collapse
|
30
|
Sainsbury AW, Yu-Mei R, Ågren E, Vaughan-Higgins RJ, Mcgill IS, Molenaar F, Peniche G, Foster J. Disease Risk Analysis and Post-Release Health Surveillance for a Reintroduction Programme: the Pool Frog Pelophylax lessonae. Transbound Emerg Dis 2016; 64:1530-1548. [PMID: 27393743 DOI: 10.1111/tbed.12545] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2015] [Indexed: 11/30/2022]
Abstract
There are risks from disease in undertaking wild animal reintroduction programmes. Methods of disease risk analysis have been advocated to assess and mitigate these risks, and post-release health and disease surveillance can be used to assess the effectiveness of the disease risk analysis, but results for a reintroduction programme have not to date been recorded. We carried out a disease risk analysis for the reintroduction of pool frogs (Pelophylax lessonae) to England, using information gained from the literature and from diagnostic testing of Swedish pool frogs and native amphibians. Ranavirus and Batrachochytrium dendrobatidis were considered high-risk disease threats for pool frogs at the destination site. Quarantine was used to manage risks from disease due to these two agents at the reintroduction site: the quarantine barrier surrounded the reintroduced pool frogs. Post-release health surveillance was carried out through regular health examinations of amphibians in the field at the reintroduction site and collection and examination of dead amphibians. No significant health or disease problems were detected, but the detection rate of dead amphibians was very low. Methods to detect a higher proportion of dead reintroduced animals and closely related species are required to better assess the effects of reintroduction on health and disease.
Collapse
Affiliation(s)
- A W Sainsbury
- Institute of Zoology, Zoological Society of London, London, UK
| | - R Yu-Mei
- Royal Veterinary College, London, UK
| | - E Ågren
- National Veterinary Institute, Uppsala, Sweden
| | | | - I S Mcgill
- Institute of Zoology, Zoological Society of London, London, UK.,Prion Interest Group, Brighton, UK
| | - F Molenaar
- Institute of Zoology, Zoological Society of London, London, UK
| | - G Peniche
- Institute of Zoology, Zoological Society of London, London, UK
| | - J Foster
- Amphibian and Reptile Conservation, Wareham, Dorset, UK
| |
Collapse
|
31
|
Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J, Trigg W, Michael-Titus AT. In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid. Eur J Nucl Med Mol Imaging 2016; 43:1710-22. [PMID: 27154521 PMCID: PMC4932147 DOI: 10.1007/s00259-016-3391-8] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2015] [Accepted: 04/04/2016] [Indexed: 12/30/2022]
Abstract
Purpose Traumatic spinal cord injury (SCI) is a devastating condition which affects millions of people worldwide causing major disability and substantial socioeconomic burden. There are currently no effective treatments. Modulating the neuroinflammatory (NI) response after SCI has evolved as a major therapeutic strategy. PET can be used to detect the upregulation of the 18-kDa translocator protein (TSPO), a hallmark of activated microglia in the CNS. We investigated whether PET imaging using the novel TSPO tracer [18F]GE-180 can be used as a clinically relevant biomarker for NI in a contusion SCI rat model, and we present data on the modulation of NI by the lipid docosahexaenoic acid (DHA). Methods A total of 22 adult male Wistar rats were subjected to controlled spinal cord contusion at the T10 spinal cord level. Six non-injured and ten T10 laminectomy only (LAM) animals were used as controls. A subset of six SCI animals were treated with a single intravenous dose of 250 nmol/kg DHA (SCI-DHA group) 30 min after injury; a saline-injected group of six animals was used as an injection control. PET and CT imaging was carried out 7 days after injury using the [18F]GE-180 radiotracer. After imaging, the animals were killed and the spinal cord dissected out for biodistribution and autoradiography studies. In vivo data were correlated with ex vivo immunohistochemistry for TSPO. Results In vivo dynamic PET imaging revealed an increase in tracer uptake in the spinal cord of the SCI animals compared with the non-injured and LAM animals from 35 min after injection (P < 0.0001; SCI vs. LAM vs. non-injured). Biodistribution and autoradiography studies confirmed the high affinity and specific [18F]GE-180 binding in the injured spinal cord compared with the binding in the control groups. Furthermore, they also showed decreased tracer uptake in the T10 SCI area in relation to the non-injured remainder of the spinal cord in the SCI-DHA group compared with the SCI-saline group (P < 0.05), supporting a NI modulatory effect of DHA. Immunohistochemistry showed a high level of TSPO expression (38 %) at the T10 injury site in SCI animals compared with that in the non-injured animals (6 %). Conclusion [18F]GE-180 PET imaging can reveal areas of increased TSPO expression that can be visualized and quantified in vivo after SCI, offering a minimally invasive approach to the monitoring of NI in SCI models and providing a translatable clinical readout for the testing of new therapies. Electronic supplementary material The online version of this article (doi:10.1007/s00259-016-3391-8) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- J L Tremoleda
- Centre for Trauma Sciences, The Blizard Institute, London, UK.
| | - O Thau-Zuchman
- Centre for Trauma Sciences, The Blizard Institute, London, UK
| | - M Davies
- Centre for Trauma Sciences, The Blizard Institute, London, UK
| | - J Foster
- Barts Cancer Institute, Queen Mary University London, London, UK
| | - I Khan
- GE Healthcare Ltd, Amersham, UK
| | - K C Vadivelu
- Centre for Trauma Sciences, The Blizard Institute, London, UK
| | - P K Yip
- Centre for Trauma Sciences, The Blizard Institute, London, UK
| | - J Sosabowski
- Barts Cancer Institute, Queen Mary University London, London, UK
| | - W Trigg
- GE Healthcare Ltd, Amersham, UK
| | | |
Collapse
|
32
|
Mangion K, Berry C, Foster J, Nowicki S, Sattar N, O’Rourke N, Glegg M, Sankaralingham M, Paul J, Lawless C, Stobo J, Mohammed N, Radjenovic A. 16 The cardiac toxicity CMR study in patients with lung cancer treated with chemo-radiotherapy: The cart study- a semi quantitative analysis of the myocardial perfusion index. Heart 2016. [DOI: 10.1136/heartjnl-2016-309668.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
33
|
Kim A, Karotki A, Foster J, Yip K, Presutti J, Wong S, Chu W. EP-1308: Effect of prone and supine positions on setup and organ-atrisk sparing using VMAT for rectal cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32558-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
34
|
Webb J, Foster J, Poulter E. Increasing the frequency of physical activity very brief advice for cancer patients. Development of an intervention using the behaviour change wheel. Public Health 2016; 133:45-56. [PMID: 26822162 DOI: 10.1016/j.puhe.2015.12.009] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Revised: 11/20/2015] [Accepted: 12/20/2015] [Indexed: 01/20/2023]
Abstract
BACKGROUND Being physically active has multiple benefits for cancer patients. Despite this only 23% are active to the national recommendations and 31% are completely inactive. A cancer diagnosis offers a teachable moment in which patients might be more receptive to lifestyle changes. Nurses are well placed to offer physical activity advice, however, only 9% of UK nurses involved in cancer care talk to all cancer patients about physical activity. A change in the behaviour of nurses is needed to routinely deliver physical activity advice to cancer patients. As recommended by the Medical Research Council, behavioural change interventions should be evidenced-based and use a relevant and coherent theoretical framework to stand the best chance of success. OBJECTIVE This paper presents a case study on the development of an intervention to improve the frequency of delivery of very brief advice (VBA) on physical activity by nurses to cancer patients, using the Behaviour Change Wheel (BCW). METHOD The eight composite steps outlined by the BCW guided the intervention development process. An iterative approach was taken involving key stakeholders (n = 45), with four iterations completed in total. This was not defined a priori but emerged during the development process. RESULTS A 60 min training intervention, delivered in either a face-to-face or online setting, with follow-up at eight weeks, was designed to improve the capability, opportunity and motivation of nurses to deliver VBA on physical activity to people living with cancer. This intervention incorporates seven behaviour change techniques of goal setting coupled with commitment; instructions on how to perform the behaviour; salience of the consequences of delivering VBA; a demonstration on how to give VBA, all delivered via a credible source with objects added to the environment to support behavioural change. CONCLUSION The BCW is a time consuming process, however, it provides a useful and comprehensive framework for intervention development and greater control over intervention replication and evaluation.
Collapse
Affiliation(s)
- J Webb
- Macmillan Cancer Support, 89 Albert Embankment, London SE1 7UQ, UK.
| | - J Foster
- Macmillan Cancer Support, 89 Albert Embankment, London SE1 7UQ, UK
| | - E Poulter
- Macmillan Cancer Support, 89 Albert Embankment, London SE1 7UQ, UK
| |
Collapse
|
35
|
Carranza C, Menendez I, Herrera M, Castellanos P, Amado C, Maldonado F, Rosales L, Escobar N, Guerra M, Alvarez D, Foster J, Guo S, Blanton SH, Bademci G, Tekin M. A Mayan founder mutation is a common cause of deafness in Guatemala. Clin Genet 2015; 89:461-465. [PMID: 26346709 DOI: 10.1111/cge.12676] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2015] [Revised: 08/14/2015] [Accepted: 09/04/2015] [Indexed: 11/29/2022]
Abstract
Over 5% of the world's population has varying degrees of hearing loss. Mutations in GJB2 are the most common cause of autosomal recessive non-syndromic hearing loss (ARNHL) in many populations. The frequency and type of mutations are influenced by ethnicity. Guatemala is a multi-ethnic country with four major populations: Maya, Ladino, Xinca, and Garifuna. To determine the mutation profile of GJB2 in a ARNHL population from Guatemala, we sequenced both exons of GJB2 in 133 unrelated families. A total of six pathogenic variants were detected. The most frequent pathogenic variant is c.131G>A (p.Trp44*) detected in 21 of 266 alleles. We show that c.131G>A is associated with a conserved haplotype in Guatemala suggesting a single founder. The majority of Mayan population lives in the west region of the country from where all c.131G>A carriers originated. Further analysis of genome-wide variation of individuals carrying the c.131G>A mutation compared with those of Native American, European, and African populations shows a close match with the Mayan population.
Collapse
Affiliation(s)
- C Carranza
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - I Menendez
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - M Herrera
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - P Castellanos
- Center for Hearing and Phonetic Training, CEDAF, Guatemala City, Guatemala
| | - C Amado
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - F Maldonado
- Therapeutic Center for Hearing and Language, CEAL, Guatemala City, Guatemala
| | - L Rosales
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - N Escobar
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - M Guerra
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - D Alvarez
- Institute for Research on Genetic and Metabolic Diseases, INVEGEM, Guatemala City, Guatemala
| | - J Foster
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - S Guo
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - S H Blanton
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - G Bademci
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | - M Tekin
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| |
Collapse
|
36
|
Hill B, Foster J, Elliott E, Boettcher A, Sofko C, Corley E. C-44The Personality Trait Need for Cognition Affects Story Memory Performance. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Kim A, Foster J, Chu W, Karotki A. SU-E-J-21: Setup Variability of Colorectal Cancer Patients Treated in the Prone Position and Dosimetric Comparison with the Supine Position. Med Phys 2015. [DOI: 10.1118/1.4924108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
38
|
Nowicki S, Mangion K, Berry C, Sattar N, Sankaralingham M, Glegg M, Lawless C, Paul J, Stobo J, Foster J, O'Rourke N, Mohammed N. PO-0667: Cardiac toxicity in lung cancer patients after chemo-radiotherapy (CART): a pilot study. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40659-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
39
|
Krout D, Dahal R, Pramod A, Sharma B, Foster J, Boateng C, Cha J, Cao J, Zou M, Newman A, Lever J, Vaughan R, Henry L. Cocaine Photo‐affinity Analogs Bind in the S1 Binding Pocket of the Dopamine Transporter Providing a Mechanism for Competitive Inhibition of Dopamine Uptake. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.768.7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- D Krout
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - R Dahal
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - A Pramod
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - B Sharma
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - J Foster
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - C Boateng
- Med Chem SectionNIDA‐IRPBaltimoreMDUnited States
| | - J Cha
- Med Chem SectionNIDA‐IRPBaltimoreMDUnited States
| | - J Cao
- Med Chem SectionNIDA‐IRPBaltimoreMDUnited States
| | - M Zou
- Med Chem SectionNIDA‐IRPBaltimoreMDUnited States
| | - A Newman
- Med Chem SectionNIDA‐IRPBaltimoreMDUnited States
| | - J Lever
- Research Service Truman Memorial Veterans' HospitalColumbiaMOUnited States
- RadiologyUniv of MissouriColumbiaMOUnited States
| | - R Vaughan
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| | - L Henry
- Basic SciencesUniv of North Dakota Sch of Med & Health SciGrand ForksNDUnited States
| |
Collapse
|
40
|
Tsim S, Humphries C, Stobo D, Foster J, Woodward R, Dick C, Blyth K. S44 Early Contrast Kinetics During Magnetic Resonance Imaging In Patients With Suspected Mesothelioma. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.50] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
41
|
Trichet AAP, Foster J, Omori NE, James D, Dolan PR, Hughes GM, Vallance C, Smith JM. Open-access optical microcavities for lab-on-a-chip refractive index sensing. Lab Chip 2014; 14:4244-9. [PMID: 25208130 DOI: 10.1039/c4lc00817k] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Open-access optical microcavities provide a novel approach to label-free lab-on-a-chip optofluidic sensing. They offer direct access to a highly confined electromagnetic field, and yield a femtoliter detection volume. This article describes the characteristics of these devices for refractive index sensing. We show that most of the ambient noise can be removed from the refractive index data by simultaneous tracking of resonances across an array of cavities. A sensitivity of 3.5 × 10(-4) RIU is demonstrated which corresponds to detecting the refractive index change caused by the presence of 500,000 glucose molecules in aqueous solution.
Collapse
Affiliation(s)
- A A P Trichet
- Department of Materials, University of Oxford, OX1 3PH, UK.
| | | | | | | | | | | | | | | |
Collapse
|
42
|
Pastuszak J, Hill B, Foster J, Musso M, Fields K, Russ K. C-74 * Self-Reported Acute Anxiety Moderates the Relationship between IQ and Math Achievement but not Reading or Writing Achievement. Arch Clin Neuropsychol 2014. [DOI: 10.1093/arclin/acu038.255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
43
|
Sollfrank T, Hart D, Goodsell R, Foster J, Kubler A, Tan T. 2D vs 3D visualization modalities and their effects on motor related potentials. J Vis 2014. [DOI: 10.1167/14.10.311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
44
|
Abstract
BACKGROUND Birth weight is a good indicator of mothers' and neonates' nutritional status, and it contributes to the newborn baby's survival, health, growth and development. AIM This study identified social factors associated with differences in the mean birth weight of newborn babies in Jordan. METHODS This retrospective study analysed medical records to determine possible risk factors associated with differences in newborn BW in the Irbid governorate of Jordan. All full-term singleton births during the year 2010 were reviewed. Abstracted data included mother's age, educational level, and monthly family income. Newborn information included birth weight, gender and birth order. RESULTS A total of 5414 full-term singleton births were included. Of these, 15.1% were low birth weight, 73.6% were normal birth weight, and 11.3% were high birth weight. Bivariate analysis of variance revealed that low mean birth weight was associated with female gender, first-born babies, higher maternal age (>35 years), lower educational level and lower income (<500 JD). Multivariate analysis of variance revealed that mean birth weight was lower in female infants, first-born infants, infants of less educated mothers, higher age and low monthly income. LIMITATIONS The findings can be generalized to full-term singleton pregnancies in countries who share similar cultural and traditional values. CONCLUSION Education of mothers is a modifiable variable that can positively influence birth weight, particularly in the case of female and first-born infants. IMPLICATION FOR NURSING AND HEALTH POLICY The findings inform our understanding of some social factors affecting birth weights of neonates in Jordan and development of effective public health interventions that could reduce the adverse effects of such factors on newborn birth weight. Preconception and antenatal care is also important for early detection of such possible risk and targeting mothers who require early interventions and support.
Collapse
Affiliation(s)
- K Mohammad
- Maternal and Child Health and Midwifery Department, Faculty of Nursing, Jordan University of Science and Technology, Irbid, Jordan
| | | | | | | | | |
Collapse
|
45
|
McComb C, Harpur A, Yacoubian C, Leddy C, Anderson G, Shepherd S, Perry C, Shaikh MG, Foster J, Ahmed SF. MRI-based abnormalities in young adults at risk of adverse bone health due to childhood-onset metabolic & endocrine conditions. Clin Endocrinol (Oxf) 2014; 80:811-7. [PMID: 24245820 DOI: 10.1111/cen.12367] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2013] [Revised: 11/09/2013] [Accepted: 11/15/2013] [Indexed: 02/03/2023]
Abstract
OBJECTIVE Traditional methods of bone densitometry may not provide a comprehensive assessment of bone health. We aimed to assess bone micro-architecture and bone marrow adiposity (BMA) by MRI in adults with osteogenesis imperfecta (OI) and endocrinopathy including GH deficiency and/or hypogonadism. MEASUREMENTS High-resolution micro-MRI images were acquired at the tibia using 3T MRI to calculate parameters of bone micro-architecture in seven adults with OI and 10 adults with endocrinopathies. MR Spectroscopy was performed in participants to calculate vertebral BMA, which was expressed as percentage fat fraction (%FF). Lumbar spine DXA was performed to assess bone mineral density. The MRI data were compared with a group of 22 healthy adults who were divided into two age-matched control groups. RESULTS Intra-operator repeatability was high, with an average CoV of 1% for micro-MRI and 2·5% for MRS. The ratio of apparent bone volume to total volume (appBV/TV) in the endocrinopathy and OI groups was lower than in age-matched control groups (P = 0·003 and P = 0·008 respectively). A weak association between DXA BMD and appBV/TV was also observed (r = 0·5, P = 0·045). %FF was higher in the endocrinopathy group than in the age-matched control group (P = 0·005), but no difference in %FF was observed between the OI group and their age-matched control group (P = 0·26). CONCLUSIONS MRI provides valuable detailed information on the micro-architecture and adiposity of bones and is capable of showing clear differences in bone parameters in a range of clinical conditions associated with abnormal bone health.
Collapse
Affiliation(s)
- C McComb
- Department of Clinical Physics, NHS Greater Glasgow & Clyde, Glasgow, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Tekin D, Tutar E, Ozturkmen Akay H, Blanton S, Foster J, Tekin M. Comprehensive genetic testing can save lives in hereditary hearing loss. Clin Genet 2014; 87:190-1. [PMID: 24689698 DOI: 10.1111/cge.12376] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2014] [Accepted: 03/10/2014] [Indexed: 11/26/2022]
Affiliation(s)
- D Tekin
- Department of Physiology, Ankara University School of Medicine, Ankara, Turkey
| | | | | | | | | | | |
Collapse
|
47
|
Foster J. Robert Marius Foster. Assoc Med J 2014. [DOI: 10.1136/bmj.f7518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
48
|
Foster J, Kapoor S, Diaz-Horta O, Singh A, Abad C, Rastogi A, Moharana R, Tekeli O, Walz K, Tekin M. Identification of an IGSF3 mutation in a family with congenital nasolacrimal duct obstruction. Clin Genet 2013; 86:589-91. [PMID: 24372406 DOI: 10.1111/cge.12321] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2013] [Revised: 11/04/2013] [Accepted: 11/12/2013] [Indexed: 11/30/2022]
Affiliation(s)
- J Foster
- Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
McGeoch RJ, Payne AR, Woodward R, Saul A, Steedman T, Foster J, Hood S, Peat E, Lindsay MM, Petrie MC, Rae AP, McEntegart M, Eteiba H, Tzemos N, Oldroyd KG, Berry C. Diagnostic utility of cardiac magnetic resonance imaging in STEMI survivors after emergency PCI. Int J Cardiol 2013; 168:2933-4. [PMID: 23701926 DOI: 10.1016/j.ijcard.2013.03.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/21/2013] [Accepted: 03/31/2013] [Indexed: 11/29/2022]
Affiliation(s)
- R J McGeoch
- Glasgow Heart and Lung Institute, Golden Jubilee National Hospital, Clydebank, United Kingdom; Department of Cardiology Western Infirmary, Glasgow, United Kingdom.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Turaga K, Levine E, Barone R, Sticca R, Petrelli N, Lambert L, Nash G, Morse M, Adbel-Misih R, Alexander HR, Attiyeh F, Bartlett D, Bastidas A, Blazer T, Chu Q, Chung K, Dominguez-Parra L, Espat NJ, Foster J, Fournier K, Garcia R, Goodman M, Hanna N, Harrison L, Hoefer R, Holtzman M, Kane J, Labow D, Li B, Lowy A, Mansfield P, Ong E, Pameijer C, Pingpank J, Quinones M, Royal R, Salti G, Sardi A, Shen P, Skitzki J, Spellman J, Stewart J, Esquivel J. Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol 2013; 21:1501-5. [PMID: 23793364 DOI: 10.1245/s10434-013-3061-z] [Citation(s) in RCA: 133] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2012] [Indexed: 11/18/2022]
Abstract
BACKGROUND The American Society of Peritoneal Surface Malignancies (ASPSM) is a consortium of cancer centers performing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). This is a position paper from the ASPSM on the standardization of the delivery of HIPEC. METHODS A survey was conducted of all cancer centers performing HIPEC in the United States. We attempted to obtain consensus by the modified method of Delphi on seven key HIPEC parameters: (1) method, (2) inflow temperature, (3) perfusate volume, (4) drug, (5) dosage, (6) timing of drug delivery, and (7) total perfusion time. Statistical analysis was performed using nonparametric tests. RESULTS Response rates for ASPSM members (n = 45) and non-ASPSM members (n = 24) were 89 and 33 %, respectively. Of the responders from ASPSM members, 95 % agreed with implementing the proposal. Majority of the surgical oncologists favored the closed method of delivery with a standardized dual dose of mitomycin for a 90-min chemoperfusion for patients undergoing cytoreductive surgery for peritoneal carcinomatosis of colorectal origin. CONCLUSIONS This recommendation on a standardized delivery of HIPEC in patients with colorectal cancer represents an important first step in enhancing research in this field. Studies directed at maximizing the efficacy of each of the seven key elements will need to follow.
Collapse
Affiliation(s)
- K Turaga
- Medical College of Wisconsin, Milwaukee, WI, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|